NCT00200525View on ClinicalTrials.gov

Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2001

Study Completion Date

June 30, 2002

Conditions
Parkinson Disease
Interventions
DRUG

apomorphine HCl injection

Sponsors
All Listed Sponsors
lead

Mylan Bertek Pharmaceuticals

INDUSTRY